A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism

Completed · Phase 2

Conditions studied: Hypothyroidism

In brief

The North Star study is a multi-center, Phase 2, double-blind, randomized, parallel group clinical study to evaluate the safe and effective dose conversion from Levothyroxine to North Star therapy.

Key facts

Study ID

NCT05712421

Run by

Neuvosyn Laboratories, LLC

People needed

303

Starts

2023-02-28

Expected to finish

2025-09-18

Last updated by the study team

2026-02-18

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with primary hypothyroidism
• On continuous thyroid replacement therapy for at least 6 months before Study Entry
• On a stable daily dose of LT4 for a minimum of 12 weeks prior to Screening
• Agree to practice a method of contraception
• Female patients not pregnant or lactating at Screening
• Agree to practice a method of contraception of greater than 90% reliability
• Willing to give written informed consent for the Study
• Provide written authorization for use and disclosure of protected health information

You may not qualify if…

• Any clinical condition or previous surgery that might affect the absorption, distribution, biotransformation or excretion of North Star or levothyroxine
• Hospitalization for a major illness within 4 weeks prior to Screening
• Anticipated initiation or change in concomitant medications
• Concomitant use of prohibited medications or supplements
• Participated in another investigational new drug study within 30 days or 5 half-lives of the IMP, whichever is longer, prior to the first study drug administration.
• For female subjects, be pregnant, nursing or planning to become pregnant during the study

Where it is running

• Neuvosyn Investigational Site — Birmingham, Alabama, United States
• Neuvosyn Investigational Site — Canoga Park, California, United States
• Neuvosyn Investigational Site — Greenbrae, California, United States
• Neuvosyn Investigational Site — Toluca Lake, California, United States
• Neuvosyn Investigational Site — Farmington, Connecticut, United States
• Neuvosyn Investigational Site — Boca Raton, Florida, United States
• Neuvosyn Investigational Site — Miami, Florida, United States
• Neuvosyn Investigational Site — Miami, Florida, United States
• Neuvosyn Investigational Site — Miami, Florida, United States
• Neuvosyn Investigational Site — Miami, Florida, United States
• Neuvosyn Investigational Site — Miami, Florida, United States
• Neuvosyn Investigational Site — Sunrise, Florida, United States
• Neuvosyn Investigational Site — Acworth, Georgia, United States
• Neuvosyn Investigational Site — Atlanta, Georgia, United States
• Neuvosyn Investigational Site — Columbus, Georgia, United States
• Neuvosyn Investigational Site — Sugar Hill, Georgia, United States
• Neuvosyn Investigational Site — Saginaw, Michigan, United States
• Neuvosyn Investigational Site — Gladstone, Missouri, United States
• Neuvosyn Investigational Site — Williamsville, New York, United States
• Neuvosyn Investigational Site — Denver, North Carolina, United States
• Neuvosyn Investigational Site — Winston-Salem, North Carolina, United States
• Neuvosyn Investigational Site — Beavercreek, Ohio, United States
• Neuvosyn Investigational Site — Columbus, Ohio, United States
• Neuvosyn Investigational Site — Georgetown, Texas, United States
• Neuvosyn Investigational Site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.